Custom Enquiry
We aim to give you a response from a qualified scientist within a hour.
Review The SDS Document
DOWNLOADProduct Details
Formula
C28H24ClF3N4O6S
MW
637.04
Purity
>97%
Solubility (DMSO Mg/MI)
31
Bio Chemical Notes
Marketed for the treatment of advanced renal cell carcinoma, Sorafenib is an inhibitor of several tyrosine protein kinases (VEGRF & PDGRF) and serine/threonine Raf kinases (C-Raf & B-Raf). Ref: Molecular Cancer Therapeutics 2008; 7; 3129.